| 摘要 |
<p>In one aspect, the present invention provides for a compound of Formula (I) in which, the variables X1, X2a, X2b, X2c, R1, B, L, E, A and the subscript n are as defined herein. In another aspect, the present invention provides for pharmaceutical compositions comprising compounds of Formula (I) as well as methods for using compounds of Formula (I) for the treatment of diseases and conditions (e.g., cancer, thrombocythemia, etc) characterized by the expression or over-expression of Bcl-2 anti-apoptotic proteins, e.g., of anti-apoptotic Bcl-xL proteins.</p> |
| 申请人 |
GENENTECH, INC.;THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH;ABBOTT LABORATORIES;BAELL, JONATHON, BAYLDON;BUI, CHINH, THIEN;COLMAN, PETER;DUDLEY, DANETTE, A.;FAIRBROTHER, WAYNE, J.;FLYGARE, JOHN, A.;LASSENE, GUILLAUME, LAURENT;NDUBAKU, CHUDI;NIKOLAKOPOULOS, GEORGE;RYE, CARL, STEVEN;SLEEBS, BRAD, EDMUND;SMITH, BRIAN, JOHN;WATSON, KEITH, GEOFFREY;ELMORE, STEVEN, W.;PETROS, ANDREW, M.;SOUERS, ANDREW, J. |
发明人 |
BAELL, JONATHON, BAYLDON;BUI, CHINH, THIEN;COLMAN, PETER;DUDLEY, DANETTE, A.;FAIRBROTHER, WAYNE, J.;FLYGARE, JOHN, A.;LASSENE, GUILLAUME, LAURENT;NDUBAKU, CHUDI;NIKOLAKOPOULOS, GEORGE;RYE, CARL, STEVEN;SLEEBS, BRAD, EDMUND;SMITH, BRIAN, JOHN;WATSON, KEITH, GEOFFREY;ELMORE, STEVEN, W.;PETROS, ANDREW, M.;SOUERS, ANDREW, J. |
